BRIEF-Voyager Therapeutics announces updates from phase 1B trial of VY-AADC01

* Voyager Therapeutics announces updates from phase 1b trial of vy-aadc01 for advanced parkinson's disease
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.